Advertisement

Topics

Cancer Reports

02:27 EST 20th November 2017 | BioPortfolio

Human Papillomavirus HPV Associated Cancer Pipeline Review, H2 2017 [Report Updated: 10102017] Prices from USD $2000

Human Papillomavirus HPV Associated Cancer Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus HPV Associated Cancer Pipeline Review, H2 2017, provides an overview of the Human Papillomavirus HPV Associated Cancer Oncology pipeline landscape.Human papillomavirus HPV is the most common viral infection of the repro...

Global and Regional Breast Implants Market Research Report 2017 [Report Updated: 25102017] Prices from USD $3500

SummaryBreast implants are medical devices that are implanted under the breast tissue or under the chest muscle to increase breast size augmentation or to rebuild breast tissue after mastectomy or other damage to the breast reconstruction. Breast implants are also used in revision surgeries, which correct or improve the result of an original surgery.Market Segment as follows:By Region AsiaPacif...

Verastem Inc VSTM Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryVerastem Inc Verastem is a biopharmaceutical company that discovers and develops drugs to treat cancer by the targeted killing of cancer stem cells. The company's products include VS6063, VS4718 and VS5584. Its VS6063 is used for the treatment of lung cancer, mesothelioma, and ovarian cancer. Verastem's VS4718 and VS5584 is used for the treatment of solid tumors and lymphomas. The company d...

IDL Biotech AB IDL B Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryIDL Biotech AB IDL Biotech is a healthcare products provider that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include breast, colorectal, lung, ovarian and prostate cancer. IDL Biotech offers serum and urine analysi...

Aethlon Medical Inc AEMD Medical Equipment Deals and Alliances Profile [Report Updated: 25102017] Prices from USD $250

SummaryAethlon Medical Inc Aethlon Medical is a developer of immunotherapeutic technologies for the treatment of infectious diseases and cancer. The company's lead product, Hemopurifier, strengthens natural immunity in human immunodeficiency virus and hepatitis C virus infected patients. Its other pipeline products include HER2osome, for combating HER2+ breast cancer; and ELLSA exosome assay, whic...

OncBioMune Pharmaceuticals Inc OBMP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryOncBioMune Pharmaceuticals Inc OncBioMune, formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company's products comprise biosimilars and vaccines developed for various cancer types such as breast, prostrate, renal and ovarian cancer. Its lead product ProscaVax, a therapeutic vaccine is developed for prostate cancer patients; and O...

Basilea Pharmaceutica Ltd BSLN Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryBasilea Pharmaceutica Ltd Basilea is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company's products address increasing resistance and nonresponse to present treatment options for various therapeutic areas such as cancer, bacterial infections and fungal infections, among others. Basilea also conducts research in the areas of antiinfe...

Colorectal Cancer Drug Development Pipeline Review, 2017 [Report Updated: 22092017] Prices from USD $3995

Colorectal Cancer Drug Development Pipeline Review, 2017SummaryThis report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.Anal cancer starts in the anus. Symp...

Guided Therapeutics Inc GTHP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryGuided Therapeutics Inc GTI, formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the noninvasive cervical cancer detection markets. Its products include luviva advanced cervical scan and esophageal dysplasia detection system. GTI develops technology to painlessly detect dis...

Pancreatic Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Pancreatic Cancer Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Pancreatic Cancer Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.This...

Global and Regional HPV Testing Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500

SummaryThe human papillomavirus HPV test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three subsegments, namely, followup testing, cotesting, HPV primary testing.Market Segment as follows:By Region AsiaPacific North America Europe South Amer...

TapImmune Inc TPIV Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryTapImmune Inc TapImmune is a clinicalstage immunooncology company specializing in the development of innovative peptide, genebased immunotherapeutics and vaccines for the treatment of cancer and metastatic disease. The company's pipeline products include TPIV 200, which is intended for the treatment of ovarian and breast cancers. It combines set of licensed technologies, including peptide a...

Global and Regional Intravesical Bacillus Calmette Market Research Report 2017 [Report Updated: 11102017] Prices from USD $3500

SummaryIntravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.Market Segment as follows:By Region AsiaPacific North America Europe South Amer...

CanFite BioPharma Ltd CANF Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryCanFite BioPharma Ltd CanFite is a biopharmaceutical company that offers pharmaceutical discovery and clinical development services. The company's pipeline product portfolio includes CF101, CF102 and CF602. It develops its products by utilizing its platform technology based on the Gi protein coupled A3 adenosine receptor A3AR in inflammatory and cancer cells. CanFite developes drugs that ar...

Bladder cancer Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Bladder cancer Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Bladder cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Bladder cancer prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk fact...

Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 2017 to 2021 [Report Updated: 30102017] Prices from USD $2800

The Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Cancer Angiogenesis Inhibitor industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its dis...

Scancell Holdings Plc SCLP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryScancell Holdings Plc Scancell is a pharmaceutical company that manufactures and markets cancer treatment products. The company offers SCIB1, a cancer vaccine that is used in the treatment of melanoma. Its product stimulates immune responses to the lung cancer antigen NYESO1. Its SCIB2 scancell Immunobody immunotherapy platform enhances the uptake and presentation of cancer antigens to harn...

Bile Duct Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Bile Duct Cancer Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Bile Duct Cancer Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.This r...

Hodgkin's Lymphoma Forecast in 17 Major Markets 20162026 [Report Updated: 02102016] Prices from USD $4930

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Hodgkin's Lymphoma in 17 Major MarketsHodgkin's Lymphoma HL is a cancer also known as Hodgkin Disease, Hodgkin Lymphoma or Hodgkin's Disease of the lymphatic system and is one of two common types of cancers of the lymphatic system. The inclusion of Reed Sternberg cells, a type of white blood cell called a B lymphocyte, helps clinic...

TesoRx Pharma LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17102017] Prices from USD $250

SummaryTesoRx Pharma LLC TesoRx is a pharmaceutical company that develops treatments to address unmet medical needs. The company's product pipeline includes, TBC1002, a novel chemotherapy approach being developed for the treatment of nonmuscle invasive bladder cancer; TSX002, an oral testosterone treatment for constitutional delay of growth in puberty ; and THG1001, an oral testosterone replacemen...

Global and Regional Bladder Scanners Market Research Report 2017 [Report Updated: 06112017] Prices from USD $3500

SummaryA bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder after urination as a way to measure residual levels. The type of scanner is a niche ultrasound system that provides fast and reliable information to aid in the diagnosis and treatment of urological conditions, access...

Colorectal Cancer CRC Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Colorectal Cancer CRC Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Colorectal Cancer CRC in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Colorectal Cancer CRC prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the...

Global and Regional Capecitabine Market Research Report 2017 [Report Updated: 08112017] Prices from USD $3500

SummaryCapecitabine is an orallyadministered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil antimetabolite in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.Market Segment as follows:By Region AsiaPacific North America Europe South America ...

Global Breast Biopsy Devices Market Research Report 20112023 [Report Updated: 08112017] Prices from USD $2030

SummaryBreast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is cancerous.The global Breast Biopsy Devices market will reach xxx Million USD in 2017 with CAG...

MetaStat Inc MTST Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryMetaStat Inc MetaStat is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable targets. It offers products such as MetaSite Breast, an immunohistochemistrybased assay developed to p...

Quick Search
Advertisement
 

review and buy Cancer market research data and corporate reports here